The first nano-robot antibodies to fight cancer were developed by Israeli researchers. Soon the new nano-robots will be subjected to the first human tests to evaluate the effectiveness of antibodies. These special antibodies are unique in that they are designed to determine whether the cells surrounding tumors are "good" or "bad".
The experiment is currently being carried out in Australia, and if all goes as planned, the nano-robot antibodies will be able to fight tumor-supporting cells while simultaneously increasing the cells' ability to inhibit the formation of malignant cells. The antibodies are based on both human and animal antibodies and were created by Professor Yanay Ofran.
According to Ofran, the purpose of these nano-robot antibodies is to make full use of what the antibodies can deliver. The potential of these organic disease fighters is currently only partially utilized in the medical use of antibodies. Therefore, maximizing their potential has been a long-term goal for some time.
These antibodies are more attractive as a means of combating common diseases such as cancer, as they can be effective for years and are safe, stable, and even simple to use. Therefore, they are more shelf-stable than viruses that treat cancer that are just beginning to circulate.
However, antibody therapy is not just for cancer. These nano-robot antibodies are useful for a variety of purposes, as they can be developed on a computer to do additional tasks.
Thanks to their programmability, they can examine their environment and even behave differently depending on the situation to help fend off diseases, infections, and more. These antibodies were the first computer-designed antibodies to be tested on humans, a significant achievement for Ofran and other researchers in the field.
We can hope that these nano-robot antibodies will continue to be effective and will be used more widely in the future. Also, this isn't the first time nanorobots have been used in medicine. Scientists have previously created tiny nanobots from frog cells in the hopes that they will help some patients avoid heart attacks.
Günceleme: 25/11/2022 12:31